Download PDF
Exp Clin Endocrinol Diabetes 2019; 127(08): 557-566
DOI: 10.1055/a-0672-0908
Article
© Georg Thieme Verlag KG Stuttgart · New York

Interaction Between Lactate and Uric Acid is Associated With a Higher Prevalence of Metabolic Syndrome: A Community-Based Study

Hua Pan   *
1   Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China
,
Dan Yan   *
1   Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China
,
Mingtong Xu
1   Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China
,
Feng Li
1   Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China
,
Meng Ren
1   Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China
,
Jin Zhang
1   Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China
,
Muchao Wu
1   Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China
› Author Affiliations
Further Information

Publication History

received 20 May 2018
revised 25 July 2018

accepted 08 August 2018

Publication Date:
10 September 2018 (online)

Also available at
    Permissions and Reprints

Abstract

Background Increased blood lactate or uric acid (UA) levels are associated with an increased risk of metabolic syndrome (MS). The aim of this study was to investigate the effect of an interactive association between blood lactate and UA levels on MS.

Methods This community-based cross-sectional study included 2584 Chinese subjects aged ≥ 18 years. Participants were classified into 3 groups based on lactate or UA level tertiles or into 9 groups based on a combination of lactate and UA level tertiles.

Results The serum high-sensitivity C-reactive protein (hs-CRP) and homeostatic model assessment of insulin resistance (HOMA-IR) levels and odds ratios (ORs) for MS increased across the blood lactate or UA level tertiles (all P for trend<0.05). Interactions between lactate and UA with hs-CRP level, HOMA-IR level, and ORs for MS (P<0.05 for all interactions) were also observed. The adjusted ORs for MS in participants in the third tertile of lactate and UA levels, in the third tertile of lactate levels and first tertile of UA levels, and in the first tertile of lactate levels and third tertile of UA levels were 6.02 (95% CI 2.87–12.64, P<0.001), 2.92 (95% CI 1.39–6.10, P=0.005), and 2.70 (95% CI 1.23–5.96, P=0.014), respectively, compared with those in the first tertiles of both lactate and UA levels.

Conclusion The interaction between lactate and UA is associated with a higher prevalence of MS in the Chinese population.

Key words

lactate - uric acid - inflammation - insulin resistance - metabolic syndrome - epidemiology

* Contributed equally


 

  • References

  • 1 Zhang GM, Zhu Y, Ye DW. Metabolic syndrome and renal cell carcinoma. World J Surg Oncol 2014; 12: 236
    CrossrefPubMedSearch in Google Scholar
  • 2 Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014; 2014: 943162
    PubMedSearch in Google Scholar
  • 3 Crawford SO, Hoogeveen HC, Brancati FL. et al. Association of blood lactate with type 2 diabetes: The atherosclerosis risk in communities carotid MRI study. Int J Epidemiol 2010; 39: 1647-1655
    CrossrefPubMedSearch in Google Scholar
  • 4 Juraschek SP, Shantha GPS, Chu AY. et al. Lactate and risk of incident diabetes in a case-cohort of the atherosclerosis risk in communities (ARIC) study. PLoS One 2013; 8: e55113
    CrossrefPubMedSearch in Google Scholar
  • 5 Billiet L, Doaty S, Katz JD. et al. Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol 2014; 2014: 852954
    CrossrefPubMedSearch in Google Scholar
  • 6 Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond) 2009; 33: 54-66
    CrossrefPubMedSearch in Google Scholar
  • 7 Tsushima Y, Nishizawa H, Tochino Y. et al. Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem 2013; 288: 27138-27149
    CrossrefPubMedSearch in Google Scholar
  • 8 Samuvel DJ, Sundararaj KP, Nareika A. et al. Lactate boosts TLR4 signaling and NF-kappaB pathway-mediated gene transcription in macrophages via monocarpboxylate transporters and MD-2 up-regulation. J Immunol 2009; 182: 2476-2484
    CrossrefPubMedSearch in Google Scholar
  • 9 Miao H, Chen L, Hao L. et al. Stearic acid induces proinflammatory cytokine production partly through activation of lactate-HIF1α pathway in chondrocytes. Sci Rep 2015; 5: 13092
    CrossrefPubMedSearch in Google Scholar
  • 10 Emanuela F, Grazia M, Marco de R. et al. Inflammation as a link between obesity and metabolic syndrome. J Nutr Metab 2012; 2012: 476380
    PubMedSearch in Google Scholar
  • 11 Kippen I, Klinenberg JR, Weinberger A. et al. Factors affecting urate solubility in vitro. Ann Rheum Dis 1974; 33: 313-317
    CrossrefPubMedSearch in Google Scholar
  • 12 Ye W, Zheng Y, Zhang S. et al. Oxamate improves glycemic control and insulin sensitivity via inhibition of tissue lactate production in db/db mice. PLoS One 2016; 11: e0150303
    CrossrefPubMedSearch in Google Scholar
  • 13 Baldwin W, McRae S, Marek G. et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 2011; 60: 1258-1269
    CrossrefPubMedSearch in Google Scholar
  • 14 Granchi C, Bertini S, Macchia M. et al. Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials. Curr Med Chem 2010; 17: 672-697
    CrossrefPubMedSearch in Google Scholar
  • 15 Takir M, Kostek O, Ozkok A. et al. Lowering uric acid with allopurinol improves insulin resistance and systemic inflammation in asymptomatic hyperuricemia. J Investig Med 2015; 63: 924-929
    CrossrefPubMedSearch in Google Scholar
  • 16 Liu P, Wang H, Zhang F. et al. The Effects of allopurinol on the carotid intima-media thickness in patients with type 2 diabetes and asymptomatic hyperuricemia: A three-year randomized parallel-controlled study. Intern Med 2015; 54: 2129-2137
    CrossrefPubMedSearch in Google Scholar
  • 17 Mongraw-Chaffin ML, Matsushita K, Brancati FL. et al. Diabetes medication use and blood lactate level among participants with type 2 diabetes: the atherosclerosis risk in communities carotid MRI study. PLoS One 2012; 7: e51237
    CrossrefPubMedSearch in Google Scholar
  • 18 Matsushita K, Williams EK, Mongraw-Chaffin ML. et al. The association of plasma lactate with incident cardiovascular outcomes: The ARIC study. Am J Epidemiol 2013; 178: 401-409
    CrossrefPubMedSearch in Google Scholar
  • 19 Muraki I, Tanigawa T, Yamagishi K. et al. Nocturnal intermittent hypoxia and C reactive protein among middle-aged community residents: A cross-sectional survey. Thorax 2010; 65: 523-527
    CrossrefPubMedSearch in Google Scholar
  • 20 Lee JM, Okumura MJ, Davis MM. et al. Prevalence and determinants of insulin resistance among U.S. adolescents: A population-based study. Diabetes Care 2006; 29: 2427-2432
    CrossrefPubMedSearch in Google Scholar
  • 21 Chen YD, Varasteh BB, Reaven GM. Plasma lactate concentration in obesity and type 2 diabetes. Diabetes Metab 1993; 19: 348-354
    PubMedSearch in Google Scholar
  • 22 Ohlson LO, Larsson B, Björntorp P. et al. Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 1988; 31: 798-805
    PubMedSearch in Google Scholar
  • 23 Lee HK, Cho YM, Kwak SH. et al. Mitochondrial dysfunction and metabolic syndrome-looking for environmental factors. Biochim Biophys Acta 2010; 1800: 282-289
    CrossrefPubMedSearch in Google Scholar
  • 24 Gonzalez-Franquesa A, Patti ME. Insulin resistance and mitochondrial dysfunction. Adv Exp Med Biol 2017; 982: 465-520
    PubMedSearch in Google Scholar
  • 25 Marín-García J. The Role of mitochondria in the metabolic syndrome and insulin resistance. In: Marín-García J. (ed) Mitochondria and their role in cardiovascular disease. New York: Springer; 2012: 401-412
    Search in Google Scholar
  • 26 Hashimoto T, Hussien R, Oommen S. et al. Lactate sensitive transcription factor network in L6 cells: Activation of MCT1 and mitochondrial biogenesis. FASEB J 2007; 21: 2602-2612
    CrossrefPubMedSearch in Google Scholar
  • 27 Boutens L, Hooiveld GJ, Dhingra S. et al. Unique metabolic activation of adipose tissue macrophages in obesity promotes inflammatory responses. Diabetologia 2018; 61: 942-953
    CrossrefPubMedSearch in Google Scholar
  • 28 Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: Underlying causes and modification by exercise training. Compr Physiol 2013; 3: 1-58
    PubMedSearch in Google Scholar
  • 29 Ishizaka N, Ishizaka Y, Toda E. et al. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005; 25: 1038-1044
    CrossrefPubMedSearch in Google Scholar
  • 30 Lee JM, Kim HC, Cho HM. et al. Association between serum uric acid level and metabolic syndrome. J Prev Med Public Health 2012; 45: 181-187
    CrossrefPubMedSearch in Google Scholar
  • 31 Nejatinamini S, Ataie-Jafari A, Qorbani M. et al. Association between serum uric acid level and metabolic syndrome components. J Diabetes Metab Disord 2015; 14: 70
    CrossrefPubMedSearch in Google Scholar
  • 32 Ford ES, Li C, Cook S. et al. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007; 115: 2526-2532
    CrossrefPubMedSearch in Google Scholar
  • 33 Sun HL, Pei D, Lue KH. et al. Uric acid levels can predict metabolic syndrome and hypertension in adolescents: A 10-year longitudinal study. PLoS One 2015; 10: e0143786
    CrossrefPubMedSearch in Google Scholar
  • 34 Lyngdoh T, Marques-Vidal P, Paccaud F. et al. Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based colaus study. PLoS One 2011; 6: e19901
    CrossrefPubMedSearch in Google Scholar
  • 35 Netea MG, Kullberg BJ, Blok WL. et al. The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood 1997; 89: 577-582
    CrossrefPubMedSearch in Google Scholar
  • 36 di Giovine FS, Malawista SE, Thornton E. et al. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 1991; 87: 1375-1381
    CrossrefPubMedSearch in Google Scholar
  • 37 Jin M, Yang F, Yang I. et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed) 2012; 17: 656-669
    CrossrefPubMedSearch in Google Scholar
  • 38 Ghaemi-Oskouie F, Shi Y. The role of uric acid as an endogenous danger signal in immunity and inflammation. Curr Rheumatol Rep 2011; 13: 160-166
    CrossrefPubMedSearch in Google Scholar
  • 39 Denoble AE, Huffman KM, Stabler TV. et al. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci U S A 2011; 108: 2088-2093
    CrossrefPubMedSearch in Google Scholar
  • 40 Nestel P, Lyu R, Low LP. et al. Metabolic syndrome: Recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr 2007; 16: 362-367
    PubMedSearch in Google Scholar
  • 41 Xi B, He D, Hu Y. et al. Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: The China Health and Nutrition Survey in 2009. Prev Med 2013; 57: 867-871
    CrossrefPubMedSearch in Google Scholar